Copyright Reports & Markets. All rights reserved.

COVID-19 Impact on Global Transfection Technologies Market Size, Status and Forecast 2020-2026

Buy now

1 Report Overview

  • 1.1 Study Scope
  • 1.2 Key Market Segments
  • 1.3 Players Covered: Ranking by Transfection Technologies Revenue
  • 1.4 Market Analysis by Type
    • 1.4.1 Global Transfection Technologies Market Size Growth Rate by Type: 2020 VS 2026
    • 1.4.2 Lipofection
    • 1.4.3 Electroporation
    • 1.4.4 Nucleofection
    • 1.4.5 Others
  • 1.5 Market by Application
    • 1.5.1 Global Transfection Technologies Market Share by Application: 2020 VS 2026
    • 1.5.2 Research Centers & Academic/Government Institutes
    • 1.5.3 Hospitals & Clinics
    • 1.5.4 Pharmaceutical & Biotechnology Companies
    • 1.5.5 Others
  • 1.6 Coronavirus Disease 2019 (Covid-19): Transfection Technologies Industry Impact
    • 1.6.1 How the Covid-19 is Affecting the Transfection Technologies Industry
      • 1.6.1.1 Transfection Technologies Business Impact Assessment - Covid-19
      • 1.6.1.2 Supply Chain Challenges
      • 1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
    • 1.6.2 Market Trends and Transfection Technologies Potential Opportunities in the COVID-19 Landscape
    • 1.6.3 Measures / Proposal against Covid-19
      • 1.6.3.1 Government Measures to Combat Covid-19 Impact
      • 1.6.3.2 Proposal for Transfection Technologies Players to Combat Covid-19 Impact
  • 1.7 Study Objectives
  • 1.8 Years Considered

2 Global Growth Trends by Regions

  • 2.1 Transfection Technologies Market Perspective (2015-2026)
  • 2.2 Transfection Technologies Growth Trends by Regions
    • 2.2.1 Transfection Technologies Market Size by Regions: 2015 VS 2020 VS 2026
    • 2.2.2 Transfection Technologies Historic Market Share by Regions (2015-2020)
    • 2.2.3 Transfection Technologies Forecasted Market Size by Regions (2021-2026)
  • 2.3 Industry Trends and Growth Strategy
    • 2.3.1 Market Top Trends
    • 2.3.2 Market Drivers
    • 2.3.3 Market Challenges
    • 2.3.4 Porter’s Five Forces Analysis
    • 2.3.5 Transfection Technologies Market Growth Strategy
    • 2.3.6 Primary Interviews with Key Transfection Technologies Players (Opinion Leaders)

3 Competition Landscape by Key Players

  • 3.1 Global Top Transfection Technologies Players by Market Size
    • 3.1.1 Global Top Transfection Technologies Players by Revenue (2015-2020)
    • 3.1.2 Global Transfection Technologies Revenue Market Share by Players (2015-2020)
    • 3.1.3 Global Transfection Technologies Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
  • 3.2 Global Transfection Technologies Market Concentration Ratio
    • 3.2.1 Global Transfection Technologies Market Concentration Ratio (CR5 and HHI)
    • 3.2.2 Global Top 10 and Top 5 Companies by Transfection Technologies Revenue in 2019
  • 3.3 Transfection Technologies Key Players Head office and Area Served
  • 3.4 Key Players Transfection Technologies Product Solution and Service
  • 3.5 Date of Enter into Transfection Technologies Market
  • 3.6 Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type (2015-2026)

  • 4.1 Global Transfection Technologies Historic Market Size by Type (2015-2020)
  • 4.2 Global Transfection Technologies Forecasted Market Size by Type (2021-2026)

5 Transfection Technologies Breakdown Data by Application (2015-2026)

  • 5.1 Global Transfection Technologies Market Size by Application (2015-2020)
  • 5.2 Global Transfection Technologies Forecasted Market Size by Application (2021-2026)

6 North America

  • 6.1 North America Transfection Technologies Market Size (2015-2020)
  • 6.2 Transfection Technologies Key Players in North America (2019-2020)
  • 6.3 North America Transfection Technologies Market Size by Type (2015-2020)
  • 6.4 North America Transfection Technologies Market Size by Application (2015-2020)

7 Europe

  • 7.1 Europe Transfection Technologies Market Size (2015-2020)
  • 7.2 Transfection Technologies Key Players in Europe (2019-2020)
  • 7.3 Europe Transfection Technologies Market Size by Type (2015-2020)
  • 7.4 Europe Transfection Technologies Market Size by Application (2015-2020)

8 China

  • 8.1 China Transfection Technologies Market Size (2015-2020)
  • 8.2 Transfection Technologies Key Players in China (2019-2020)
  • 8.3 China Transfection Technologies Market Size by Type (2015-2020)
  • 8.4 China Transfection Technologies Market Size by Application (2015-2020)

9 Japan

  • 9.1 Japan Transfection Technologies Market Size (2015-2020)
  • 9.2 Transfection Technologies Key Players in Japan (2019-2020)
  • 9.3 Japan Transfection Technologies Market Size by Type (2015-2020)
  • 9.4 Japan Transfection Technologies Market Size by Application (2015-2020)

10 Southeast Asia

  • 10.1 Southeast Asia Transfection Technologies Market Size (2015-2020)
  • 10.2 Transfection Technologies Key Players in Southeast Asia (2019-2020)
  • 10.3 Southeast Asia Transfection Technologies Market Size by Type (2015-2020)
  • 10.4 Southeast Asia Transfection Technologies Market Size by Application (2015-2020)

11 India

  • 11.1 India Transfection Technologies Market Size (2015-2020)
  • 11.2 Transfection Technologies Key Players in India (2019-2020)
  • 11.3 India Transfection Technologies Market Size by Type (2015-2020)
  • 11.4 India Transfection Technologies Market Size by Application (2015-2020)

12 Central & South America

  • 12.1 Central & South America Transfection Technologies Market Size (2015-2020)
  • 12.2 Transfection Technologies Key Players in Central & South America (2019-2020)
  • 12.3 Central & South America Transfection Technologies Market Size by Type (2015-2020)
  • 12.4 Central & South America Transfection Technologies Market Size by Application (2015-2020)

13 Key Players Profiles

  • 13.1 Bio-Rad
    • 13.1.1 Bio-Rad Company Details
    • 13.1.2 Bio-Rad Business Overview and Its Total Revenue
    • 13.1.3 Bio-Rad Transfection Technologies Introduction
    • 13.1.4 Bio-Rad Revenue in Transfection Technologies Business (2015-2020))
    • 13.1.5 Bio-Rad Recent Development
  • 13.2 Polyplus Transfection
    • 13.2.1 Polyplus Transfection Company Details
    • 13.2.2 Polyplus Transfection Business Overview and Its Total Revenue
    • 13.2.3 Polyplus Transfection Transfection Technologies Introduction
    • 13.2.4 Polyplus Transfection Revenue in Transfection Technologies Business (2015-2020)
    • 13.2.5 Polyplus Transfection Recent Development
  • 13.3 MaxCyte
    • 13.3.1 MaxCyte Company Details
    • 13.3.2 MaxCyte Business Overview and Its Total Revenue
    • 13.3.3 MaxCyte Transfection Technologies Introduction
    • 13.3.4 MaxCyte Revenue in Transfection Technologies Business (2015-2020)
    • 13.3.5 MaxCyte Recent Development
  • 13.4 Promega Corporation
    • 13.4.1 Promega Corporation Company Details
    • 13.4.2 Promega Corporation Business Overview and Its Total Revenue
    • 13.4.3 Promega Corporation Transfection Technologies Introduction
    • 13.4.4 Promega Corporation Revenue in Transfection Technologies Business (2015-2020)
    • 13.4.5 Promega Corporation Recent Development
  • 13.5 Thermo Fisher Scientific
    • 13.5.1 Thermo Fisher Scientific Company Details
    • 13.5.2 Thermo Fisher Scientific Business Overview and Its Total Revenue
    • 13.5.3 Thermo Fisher Scientific Transfection Technologies Introduction
    • 13.5.4 Thermo Fisher Scientific Revenue in Transfection Technologies Business (2015-2020)
    • 13.5.5 Thermo Fisher Scientific Recent Development
  • 13.6 Affymetrix
    • 13.6.1 Affymetrix Company Details
    • 13.6.2 Affymetrix Business Overview and Its Total Revenue
    • 13.6.3 Affymetrix Transfection Technologies Introduction
    • 13.6.4 Affymetrix Revenue in Transfection Technologies Business (2015-2020)
    • 13.6.5 Affymetrix Recent Development
  • 13.7 Agilent Technologies
    • 13.7.1 Agilent Technologies Company Details
    • 13.7.2 Agilent Technologies Business Overview and Its Total Revenue
    • 13.7.3 Agilent Technologies Transfection Technologies Introduction
    • 13.7.4 Agilent Technologies Revenue in Transfection Technologies Business (2015-2020)
    • 13.7.5 Agilent Technologies Recent Development
  • 13.8 Altogen Biosystems
    • 13.8.1 Altogen Biosystems Company Details
    • 13.8.2 Altogen Biosystems Business Overview and Its Total Revenue
    • 13.8.3 Altogen Biosystems Transfection Technologies Introduction
    • 13.8.4 Altogen Biosystems Revenue in Transfection Technologies Business (2015-2020)
    • 13.8.5 Altogen Biosystems Recent Development
  • 13.9 Boca Scientific
    • 13.9.1 Boca Scientific Company Details
    • 13.9.2 Boca Scientific Business Overview and Its Total Revenue
    • 13.9.3 Boca Scientific Transfection Technologies Introduction
    • 13.9.4 Boca Scientific Revenue in Transfection Technologies Business (2015-2020)
    • 13.9.5 Boca Scientific Recent Development
  • 13.10 Chemicell
    • 13.10.1 Chemicell Company Details
    • 13.10.2 Chemicell Business Overview and Its Total Revenue
    • 13.10.3 Chemicell Transfection Technologies Introduction
    • 13.10.4 Chemicell Revenue in Transfection Technologies Business (2015-2020)
    • 13.10.5 Chemicell Recent Development
  • 13.11 CytoPulse
    • 10.11.1 CytoPulse Company Details
    • 10.11.2 CytoPulse Business Overview and Its Total Revenue
    • 10.11.3 CytoPulse Transfection Technologies Introduction
    • 10.11.4 CytoPulse Revenue in Transfection Technologies Business (2015-2020)
    • 10.11.5 CytoPulse Recent Development
  • 13.12 Clontech
    • 10.12.1 Clontech Company Details
    • 10.12.2 Clontech Business Overview and Its Total Revenue
    • 10.12.3 Clontech Transfection Technologies Introduction
    • 10.12.4 Clontech Revenue in Transfection Technologies Business (2015-2020)
    • 10.12.5 Clontech Recent Development
  • 13.13 Deliverics
    • 10.13.1 Deliverics Company Details
    • 10.13.2 Deliverics Business Overview and Its Total Revenue
    • 10.13.3 Deliverics Transfection Technologies Introduction
    • 10.13.4 Deliverics Revenue in Transfection Technologies Business (2015-2020)
    • 10.13.5 Deliverics Recent Development
  • 13.14 GE Healthcare Life Sciences
    • 10.14.1 GE Healthcare Life Sciences Company Details
    • 10.14.2 GE Healthcare Life Sciences Business Overview and Its Total Revenue
    • 10.14.3 GE Healthcare Life Sciences Transfection Technologies Introduction
    • 10.14.4 GE Healthcare Life Sciences Revenue in Transfection Technologies Business (2015-2020)
    • 10.14.5 GE Healthcare Life Sciences Recent Development
  • 13.15 IBA GmbH
    • 10.15.1 IBA GmbH Company Details
    • 10.15.2 IBA GmbH Business Overview and Its Total Revenue
    • 10.15.3 IBA GmbH Transfection Technologies Introduction
    • 10.15.4 IBA GmbH Revenue in Transfection Technologies Business (2015-2020)
    • 10.15.5 IBA GmbH Recent Development
  • 13.16 Lonza
    • 10.16.1 Lonza Company Details
    • 10.16.2 Lonza Business Overview and Its Total Revenue
    • 10.16.3 Lonza Transfection Technologies Introduction
    • 10.16.4 Lonza Revenue in Transfection Technologies Business (2015-2020)
    • 10.16.5 Lonza Recent Development
  • 13.17 Inovio Pharmaceuticals
    • 10.17.1 Inovio Pharmaceuticals Company Details
    • 10.17.2 Inovio Pharmaceuticals Business Overview and Its Total Revenue
    • 10.17.3 Inovio Pharmaceuticals Transfection Technologies Introduction
    • 10.17.4 Inovio Pharmaceuticals Revenue in Transfection Technologies Business (2015-2020)
    • 10.17.5 Inovio Pharmaceuticals Recent Development
  • 13.18 Merck KGaA
    • 10.18.1 Merck KGaA Company Details
    • 10.18.2 Merck KGaA Business Overview and Its Total Revenue
    • 10.18.3 Merck KGaA Transfection Technologies Introduction
    • 10.18.4 Merck KGaA Revenue in Transfection Technologies Business (2015-2020)
    • 10.18.5 Merck KGaA Recent Development
  • 13.19 Miltenyi Biotec
    • 10.19.1 Miltenyi Biotec Company Details
    • 10.19.2 Miltenyi Biotec Business Overview and Its Total Revenue
    • 10.19.3 Miltenyi Biotec Transfection Technologies Introduction
    • 10.19.4 Miltenyi Biotec Revenue in Transfection Technologies Business (2015-2020)
    • 10.19.5 Miltenyi Biotec Recent Development
  • 13.20 Oz Biosciences
    • 10.20.1 Oz Biosciences Company Details
    • 10.20.2 Oz Biosciences Business Overview and Its Total Revenue
    • 10.20.3 Oz Biosciences Transfection Technologies Introduction
    • 10.20.4 Oz Biosciences Revenue in Transfection Technologies Business (2015-2020)
    • 10.20.5 Oz Biosciences Recent Development

14 Analyst's Viewpoints/Conclusions

    15 Appendix

    • 15.1 Research Methodology
      • 15.1.1 Methodology/Research Approach
      • 15.1.2 Data Source
    • 15.2 Disclaimer

    This report focuses on the global Transfection Technologies status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Transfection Technologies development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.

    The key players covered in this study
    Bio-Rad
    Polyplus Transfection
    MaxCyte
    Promega Corporation
    Thermo Fisher Scientific
    Affymetrix
    Agilent Technologies
    Altogen Biosystems
    Boca Scientific
    Chemicell
    CytoPulse
    Clontech
    Deliverics
    GE Healthcare Life Sciences
    IBA GmbH
    Lonza
    Inovio Pharmaceuticals
    Merck KGaA
    Miltenyi Biotec
    Oz Biosciences

    Market segment by Type, the product can be split into
    Lipofection
    Electroporation
    Nucleofection
    Others
    Market segment by Application, split into
    Research Centers & Academic/Government Institutes
    Hospitals & Clinics
    Pharmaceutical & Biotechnology Companies
    Others

    Market segment by Regions/Countries, this report covers
    North America
    Europe
    China
    Japan
    Southeast Asia
    India
    Central & South America

    The study objectives of this report are:
    To analyze global Transfection Technologies status, future forecast, growth opportunity, key market and key players.
    To present the Transfection Technologies development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
    To strategically profile the key players and comprehensively analyze their development plan and strategies.
    To define, describe and forecast the market by type, market and key regions.

    In this study, the years considered to estimate the market size of Transfection Technologies are as follows:
    History Year: 2015-2019
    Base Year: 2019
    Estimated Year: 2020
    Forecast Year 2020 to 2026
    For the data information by region, company, type and application, 2019 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

    Buy now